4,10-Dioxatricyclo[5.2.1.02.6]dec-8-ene-3,5-dione

CAS: 5426-09-5

Ref. 3D-FD15512

Produktinformation

• Name: 4,10-Dioxatricyclo[5.2.1.02.6]dec-8-ene-3,5-dione
• Synonyme: 1,4-Epoxycyclohex-5-ene-2,3-dicarboxylic anhydride, 3,6-Endoxo-delta'-tetrahydrophthalic anhydride, 3,6-Epoxy-1,2,3,6-tetrahydrophthalic anhydride, 3A,4,7,7A-Tetrahydro-4,7-Epoxy-2-Benzofuran-1,3-Dione, 4,10-Dioxatricyclo[5.2.1.0^2,6]dec-8-ene-3,5-dion, 4,10-Dioxatricyclo[5.2.1.0^2,6]dec-8-ene-3,5-dione, 4,7-Epoxyisobenzofuran-1,3-dione, 3a,4,7,7a-tetrahydro-, 7-Oxabicyclo(2.2.1)-5-heptene-2,3-dicarboxylic anhydride, 7-Oxabicyclo(2.2.1)hept-5-ene-2,3-dicarboxylic anhydride, 7-Oxabicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid anhydride, Furan-maleic anhydride Diels-Alder adduct, Furan-maleic anhydride adduct, Furan-maleic anhydride copolymer, Nsc 14002, Nsc 231495, Nsc 61997

Beschreibung

4,10-Dioxatricyclo[5.2.1.02.6]dec-8-ene-3,5-dione (DTDE) is a hypoglycemic agent that inhibits the synthesis of fatty acids in the liver and reduces blood sugar levels by inhibiting the enzyme diacylglycerol acyltransferase 2 (DGAT2). DTDE has been shown to have antitumour activity against a human cell line and inhibits the replication of DNA and RNA by binding to amines in nucleic acid bases.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 166.13 g/mol
• Formel: C₈H₆O₄
• Reinheit: Min. 95%